Laraño, Chamy .

HRN: 27-04-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2025
AMPICILLIN 1GM (VIAL)
05/14/2025
05/17/2025
IVT
2g
Q6
PROM
Waiting Final Action 
05/16/2025
CEFUROXIME 1.5GM (VIAL)
05/16/2025
05/23/2025
IVT
1.5gm
Q 8 HRS
LTCS
Waiting Final Action 
05/16/2025
CEFUROXIME 1.5GM (VIAL)
05/16/2025
05/23/2025
IV
1.5g
Q8
S/p CS
Waiting Final Action 
05/17/2025
CEFUROXIME 500MG (TAB)
05/17/2025
05/24/2025
ORAL
500 Mg/tab
Bid
S/p Lstcs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: